BofA raised the firm’s price target on Amphenol (APH) to $163 from $150 and keeps a Buy rating on the shares following “a strong beat” that came in “meaningfully ahead” of Street and BofA expectations. Following the Q3 beat and fiscal Q4 guidance that came in above expectations, the firm FY25 revenue and EPS estimates move up to $22.8B and $3.30 from $22.1B and $3.05, respectively.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APH:
- Amphenol’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Amphenol price target raised to $160 from $145 at Citi
- Amphenol price target raised to $154 from $139 at Goldman Sachs
- Amphenol’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
- Amphenol Corporation Announces Record Q3 2025 Results